Aitia

Aitia, based in Somerville, MA, harnesses cutting-edge supercomputing and causal AI technologies to advance drug discovery by creating Gemini Digital Twins—innovative in silico models of human diseases. Their collaborative approach integrates extensive patient data to uncover novel intervention points, paving the way for targeted therapeutics in partnership with pharmaceutical companies.

The company's world-class team combines expertise in AI, research, and biotechnology to tackle significant unmet medical needs, including oncology and neurodegeneration. Aitia's mission is to transform drug discovery and development through shared knowledge and collaborative partnerships, leading to breakthroughs in therapeutic development.

Generated from the website